Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R de Groot

Showing results (551-560 of 568) with videos related to

Pageof 57
Sort By:
Journal of the American Heart Association|August 27, 2024
Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 TrialHans Christoph Diener, Nina Becher, Susanne Sehner, et al.
The New England Journal of Medicine|August 25, 2023
Anticoagulation with Edoxaban in Patients with Atrial High-Rate EpisodesPaulus Kirchhof, Tobias Toennis, Andreas Goette, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 30, 2024
Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)Andreas Goette, Domenico Corradi, Dobromir Dobrev, et al.
European Heart Journal|April 9, 2024
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trialGregory Y H Lip, Julius Nikorowitsch, Susanne Sehner, et al.
BMC Palliative Care|March 14, 2024
A Dutch paediatric palliative care guideline: a systematic review and evidence-based recommendations for symptom treatmentKim C van Teunenbroek, Renée L Mulder, Inge M L Ahout, et al.
European Heart Journal|November 13, 2023
Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 hNina Becher, Tobias Toennis, Emanuele Bertaglia, et al.
Haematologica|November 27, 2014
Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patientsJaap J Zwaginga, Bronno van der Holt, Peter A Te Boekhorst, et al.
Circulation. Arrhythmia and Electrophysiology|September 30, 2025
Dual Epicardial and Endocardial Procedure (DEEP) for Persistent or Longstanding Persistent Atrial FibrillationKenneth A Ellenbogen, Ali Khoynezhad, Mark La Meir, et al.
European Heart Journal Open|June 12, 2026
Design and rationale of the RISC-trial: multicentre <i>R</i>CT to assess <i>i</i>mmediate discharge of <i>s</i>yncope patients admitted to the (<i>c</i>ardiac) emergency roomThomas T Boel, Suzanne Y G Peeters, Anouk P van Alem, et al.
The New England Journal of Medicine|August 7, 2020
Subcutaneous or Transvenous Defibrillator TherapyReinoud E Knops, Louise R A Olde Nordkamp, Peter-Paul H M Delnoy, et al.
Pageof 57

Showing results (551-560 of 568) with videos related to

Sort By:
Pageof 57
Journal of the American Heart Association|August 27, 2024
Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 TrialHans Christoph Diener, Nina Becher, Susanne Sehner, et al.
The New England Journal of Medicine|August 25, 2023
Anticoagulation with Edoxaban in Patients with Atrial High-Rate EpisodesPaulus Kirchhof, Tobias Toennis, Andreas Goette, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 30, 2024
Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)Andreas Goette, Domenico Corradi, Dobromir Dobrev, et al.
European Heart Journal|April 9, 2024
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trialGregory Y H Lip, Julius Nikorowitsch, Susanne Sehner, et al.
BMC Palliative Care|March 14, 2024
A Dutch paediatric palliative care guideline: a systematic review and evidence-based recommendations for symptom treatmentKim C van Teunenbroek, Renée L Mulder, Inge M L Ahout, et al.
European Heart Journal|November 13, 2023
Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 hNina Becher, Tobias Toennis, Emanuele Bertaglia, et al.
Haematologica|November 27, 2014
Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patientsJaap J Zwaginga, Bronno van der Holt, Peter A Te Boekhorst, et al.
Circulation. Arrhythmia and Electrophysiology|September 30, 2025
Dual Epicardial and Endocardial Procedure (DEEP) for Persistent or Longstanding Persistent Atrial FibrillationKenneth A Ellenbogen, Ali Khoynezhad, Mark La Meir, et al.
European Heart Journal Open|June 12, 2026
Design and rationale of the RISC-trial: multicentre <i>R</i>CT to assess <i>i</i>mmediate discharge of <i>s</i>yncope patients admitted to the (<i>c</i>ardiac) emergency roomThomas T Boel, Suzanne Y G Peeters, Anouk P van Alem, et al.
The New England Journal of Medicine|August 7, 2020
Subcutaneous or Transvenous Defibrillator TherapyReinoud E Knops, Louise R A Olde Nordkamp, Peter-Paul H M Delnoy, et al.
Pageof 57